SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-18-000239
Filing Date
2018-01-05
Accepted
2018-01-05 17:04:16
Documents
13

Document Format Files

Seq Description Document Type Size
1 form-3.htm S-3 1202030
2 ex1-2.htm EX-1.2 282092
3 ex4-5.htm EX-4.5 550931
4 ex4-6.htm EX-4.6 590751
5 ex5-1.htm EX-5.1 29489
6 ex12-1.htm EX-12.1 118359
7 ex23-1.htm EX-23.1 3763
8 image_001.jpg GRAPHIC 3758
9 image_002.jpg GRAPHIC 3792
10 image_003.jpg GRAPHIC 4664
11 image_004.jpg GRAPHIC 3791
12 image_005.jpg GRAPHIC 4664
13 image_006.jpg GRAPHIC 3791
  Complete submission text file 0001493152-18-000239.txt   2812858
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222447 | Film No.: 18514094
SIC: 2834 Pharmaceutical Preparations